A pilot study discovered that the FSHR Ser680Asn genotype does not influence the follicular fluid hormonal profile or ovulation outcomes in cycles stimulated with varying gonadotropin preparations. The research, involving 40 women undergoing ART, compared two genetic variants and determined no significant impact on treatment results.
Read More
India vs Zimbabwe 3rd T20I Highlights: Crucial Win by 23 Runs Gives India Edge in Series
Inter Miami's Triumph Continues: Victory Over Nashville SC Makes It Three in a Row
Jadon Sancho's Impact on Manchester United's Summer Transfer Strategy
MIT's Innovative Approach to Teaching Robots Their Operational Limits for Enhanced Safety
Chelsea vs Aston Villa WSL Opener: A Thrilling Start to the 2024-2025 Season
